HB 2676 Kansas House · 2025-2026 Regular Session

Permitting a pharmacist to initiate therapy for certain conditions consistent with the pharmacist's education, training and experience, adding pharmacists who initiate such therapy to the healthcare stabilization fund and allowing a pharmacist to dispense a one-time emergency refill of a noncontrolled prescription drug for up to a 90-day supply when no refills remain.

HB 2676 allows Kansas pharmacists to initiate therapy for specific minor health conditions, such as influenza, strep throat, and urinary tract infections, without a physician's direct order, provided the condition is minor, self-limiting, or meets other defined criteria like not requiring a new diagnosis. Pharmacists must follow statewide protocols developed by a committee, which specify required training, documentation, communication with the patient's primary care provider, and adherence to the standard of care. Violations of these protocols could lead to disciplinary action by the state board, including license suspension. The law became effective on July 1, 2022.
Bill status died 3 of 5 stages cleared
Introduction
Feb 2026
Committee Review
Feb 2026
House Passage
Feb 2026
Senate Passage
Governor
Introduced Feb 3, 2026 Last action Apr 10, 2026
Maddy AI version diff · 1 comparison

What changed between versions

As Introduced As Amended by House Committee · 8 edits
MODERATE
The bill was amended to expand its scope beyond just pharmacist practice authority to include broader healthcare liability insurance requirements. The title and summary now explicitly mention adding pharmacists to a healthcare stabilization fund, allowing 90-day emergency drug supplies, and amending insurance statutes. The substantive text shows a significant shift from repealing a specific pharmacist section to amending general professional liability insurance laws, increasing coverage limits for new policies, and adding notification requirements for insurers.
Scope change
The bill's scope expanded from a narrow focus on pharmacist scope of practice to a broader amendment of professional liability insurance statutes applicable to various healthcare providers.
SCOPE

The bill's purpose was broadened from solely regulating pharmacist therapy initiation to also addressing healthcare liability insurance standards and emergency drug supply provisions.

The specific section detailing the collaborative drug therapy management advisory committee and its authority to adopt statewide protocols for pharmacist therapy was removed.

REQUIREMENT

Professional liability insurance limits for new policies were increased from $200,000/$600,000 to $500,000/$1,500,000, though pharmacists and optometrists remain exempt from these specific increases.

New requirements were added for insurers to notify the board of governors within 30 days of issuing basic coverage and to provide at least 30 days notice before terminating coverage.

New provisions allow for a 90-day emergency supply of noncontrolled prescription drugs to be filled when no refills remain.

FISCAL

The bill now includes language adding pharmacists who initiate therapy to the healthcare stabilization fund.

ENFORCEMENT

The provision allowing the board to revoke pharmacist licenses for violating therapy protocols was removed.

TIMELINE

The effective date for the new insurance liability limits was set to January 1, 2022, replacing the previous July 1, 2022 date for the pharmacist section.

Floor votes

How they voted

This bill passed the House by voice vote (no roll call recorded).
Full legislative history

Actions timeline

Total actions
10
Key actions
4
Committee
3
Feb 26, 2026
Committee
Referred to Senate Committee on Public Health and Welfare
upper
Feb 25, 2026
Introduced
Received and Introduced
upper
Feb 19, 2026
Lower · Passed
Final Action - Passed as amended; Yea 95, Nay 27, Absent 3
lower
Feb 18, 2026
Lower · Passed
Committee of the Whole - Be passed as amended
lower
Feb 18, 2026
Lower · Passed
Committee of the Whole - Committee Report be adopted
lower
Feb 17, 2026
Lower · Passed
Committee Report recommending bill be passed as amended by House Committee on Health and Human Services
lower
Feb 3, 2026
Committee
Referred to House Committee on Health and Human Services
lower
Feb 3, 2026
Introduced
Introduced
lower
0 primary · 0 co-sponsors

Sponsors

No sponsor information available.